109 related articles for article (PubMed ID: 18588600)
1. Two cases of burning mouth syndrome treated with olanzapine.
Ueda N; Kodama Y; Hori H; Umene W; Sugita A; Nakano H; Yoshimura R; Nakamura J
Psychiatry Clin Neurosci; 2008 Jun; 62(3):359-61. PubMed ID: 18588600
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.
Maina G; Vitalucci A; Gandolfo S; Bogetto F
J Clin Psychiatry; 2002 Jan; 63(1):38-43. PubMed ID: 11838624
[TBL] [Abstract][Full Text] [Related]
3. [Burning mouth syndrome: pathogenic and therapeutic concepts].
Ferensztajn E; Łojko D; Rybakowski J
Psychiatr Pol; 2013; 47(6):973-88. PubMed ID: 25007531
[TBL] [Abstract][Full Text] [Related]
4. The effect of levosulpiride in burning mouth syndrome.
Demarosi F; Tarozzi M; Lodi G; Canegallo L; Rimondini L; Sardella A
Minerva Stomatol; 2007; 56(1-2):21-6. PubMed ID: 17287703
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine in the treatment of resistant depression.
Caetano D; Caetano SC
Aust N Z J Psychiatry; 2005; 39(1-2):108-9. PubMed ID: 15660713
[No Abstract] [Full Text] [Related]
6. Effectiveness of low-dose milnacipran for a patient suffering from pain disorder with delusional disorder (somatic type) in the orofacial region.
Ukai K; Kimura H; Arao M; Aleksic B; Yamauchi A; Ishihara R; Iritani S; Kurita K; Ozaki N
Psychogeriatrics; 2013 Jun; 13(2):99-102. PubMed ID: 23909967
[TBL] [Abstract][Full Text] [Related]
7. The dubious effect of milnacipran for the treatment of burning mouth syndrome.
Sugimoto K
Clin Neuropharmacol; 2011; 34(4):170-3. PubMed ID: 21738026
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of moclobemide in burning mouth syndrome: a nonrandomized, open-label study.
Pekiner FN; Gumru B; Ozbayrak S
J Orofac Pain; 2008; 22(2):146-52. PubMed ID: 18548844
[TBL] [Abstract][Full Text] [Related]
9. Burning mouth syndrome: Identification, diagnosis, and treatment.
Rivinius C
J Am Acad Nurse Pract; 2009 Aug; 21(8):423-9. PubMed ID: 19689438
[TBL] [Abstract][Full Text] [Related]
10. Aetiology and therapeutics of burning mouth syndrome: an update.
Spanemberg JC; Cherubini K; de Figueiredo MA; Yurgel LS; Salum FG
Gerodontology; 2012 Jun; 29(2):84-9. PubMed ID: 22612823
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy in relieving the symptoms of burning mouth syndrome: A 1-year follow-up study.
Paudel D; Utsunomiya M; Yoshida K; Giri S; Uehara O; Matsuoka H; Chiba I; Toyofuku A; Abiko Y
Oral Dis; 2020 Jan; 26(1):193-199. PubMed ID: 31705718
[TBL] [Abstract][Full Text] [Related]
12. Burning mouth syndrome: a review of recent literature.
Charleston L
Curr Pain Headache Rep; 2013 Jun; 17(6):336. PubMed ID: 23645183
[TBL] [Abstract][Full Text] [Related]
13. Five Patients With Burning Mouth Syndrome in Whom an Antidepressant (Serotonin-Noradrenaline Reuptake Inhibitor) Was Not Effective, but Pregabalin Markedly Relieved Pain.
Ito M; Tokura T; Yoshida K; Nagashima W; Kimura H; Umemura E; Tachibana M; Miyauchi T; Kobayashi Y; Arao M; Ozaki N; Kurita K
Clin Neuropharmacol; 2015; 38(4):158-61. PubMed ID: 26166242
[TBL] [Abstract][Full Text] [Related]
14. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments.
Sardella A; Lodi G; Demarosi F; Bez C; Cassano S; Carrassi A
Oral Dis; 2006 Mar; 12(2):152-5. PubMed ID: 16476036
[TBL] [Abstract][Full Text] [Related]
15. Hypericum perforatum extract in burning mouth syndrome: a randomized placebo-controlled study.
Sardella A; Lodi G; Demarosi F; Tarozzi M; Canegallo L; Carrassi A
J Oral Pathol Med; 2008 Aug; 37(7):395-401. PubMed ID: 18331283
[TBL] [Abstract][Full Text] [Related]
16. Milnacipran dose-effect study in patients with burning mouth syndrome.
Kato Y; Sato T; Katagiri A; Umezaki Y; Takenoshita M; Yoshikawa T; Sato Y; Toyofuku A
Clin Neuropharmacol; 2011; 34(4):166-9. PubMed ID: 21738023
[TBL] [Abstract][Full Text] [Related]
17. The psychological aspects of burning mouth syndrome.
Kenchadze R; Iverieli M; Okribelashvili N; Geladze N; Khachapuridze N
Georgian Med News; 2011 May; (194):24-8. PubMed ID: 21685517
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
[TBL] [Abstract][Full Text] [Related]
19. Duloxetine in the treatment of burning mouth syndrome refractory to conventional treatment: A case report.
Kim YD; Lee JH; Shim JH
J Int Med Res; 2014 Jun; 42(3):879-83. PubMed ID: 24743872
[TBL] [Abstract][Full Text] [Related]
20. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
